A total of 75 institutions have reported a stake in Kyverna Therapeutics, Inc. (NASDAQ:KYTX) as of September 2025, according to recent 13F filings with the SEC.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Vida Ventures Advisors, LLC | 30 Sep, 2025 | 4,523,924 | 0 | 0.00% | $27,143,544.00 |
| GILEAD SCIENCES, INC. | 30 Sep, 2025 | 4,126,119 | 0 | 0.00% | $24,756,714.00 |
| Bain Capital Life Sciences Investors, LLC | 30 Sep, 2025 | 3,368,370 | 0 | 0.00% | $20,210,220.00 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 30 Sep, 2025 | 1,512,199 | -318,302 | -17.39% | $9,074.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 1,322,625 | 9,858 | 0.75% | $7,935,750.00 |
| Insight Holdings Group, LLC | 30 Sep, 2025 | 989,054 | 0 | 0.00% | $5,934,324.00 |
| FRANKLIN RESOURCES INC | 30 Sep, 2025 | 677,587 | -17,440 | -2.51% | $4,065,522.00 |
| MBB PUBLIC MARKETS I LLC | 30 Sep, 2025 | 614,477 | 0 | 0.00% | $3,686,862.00 |
| Catalio Capital Management, LP | 30 Sep, 2025 | 586,909 | 0 | 0.00% | $3,521,454.00 |
| MILLENNIUM MANAGEMENT LLC | 30 Sep, 2025 | 551,635 | 99,075 | 21.89% | $3,309,810.00 |
| BlackRock, Inc. | 30 Sep, 2025 | 482,054 | -51,413 | -9.64% | $2,892,324.00 |
| Kera Capital Partners, Inc. | 30 Sep, 2025 | 421,924 | 0 | 0.00% | $2,531,544.00 |
| Peapod Lane Capital LLC | 30 Sep, 2025 | 318,760 | -78,003 | -19.66% | $1,912,199.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 278,329 | -9,272 | -3.22% | $1,670,347.00 |
| Woodline Partners LP | 30 Sep, 2025 | 252,212 | 209,735 | 493.76% | $1,513,272.00 |
| JANE STREET GROUP, LLC | 30 Sep, 2025 | 213,851 | 126,082 | 143.65% | $1,283,106.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 30 Sep, 2025 | 202,690 | 130,421 | 180.47% | $1,216,140.00 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 174,900 | 112,000 | 178.06% | $1,049,400.00 |
| MORGAN STANLEY | 30 Sep, 2025 | 174,203 | -27,835 | -13.78% | $1,045,218.00 |
| TD ASSET MANAGEMENT INC | 30 Sep, 2025 | 164,796 | -87,400 | -34.66% | $988,776.00 |